Cargando…
Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight
NU172—a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity—was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enz...
Autores principales: | Riccardi, Claudia, Meyer, Albert, Vasseur, Jean-Jacques, Cavasso, Domenico, Russo Krauss, Irene, Paduano, Luigi, Morvan, François, Montesarchio, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312020/ https://www.ncbi.nlm.nih.gov/pubmed/32485818 http://dx.doi.org/10.3390/ijms21113860 |
Ejemplares similares
-
Charge-Transfer Interactions Stabilize G-Quadruplex-Forming Thrombin Binding Aptamers and Can Improve Their Anticoagulant Activity
por: Pérez de Carvasal, Kévan, et al.
Publicado: (2021) -
Synthesis and Characterization of Multifunctional Nanovesicles Composed of POPC Lipid Molecules for Nuclear Imaging
por: Petroni, Debora, et al.
Publicado: (2021) -
Several structural motifs cooperate in determining the highly effective anti-thrombin activity of NU172 aptamer
por: Troisi, Romualdo, et al.
Publicado: (2018) -
Controlling
the Adsorption of β-Glucosidase
onto Wrinkled SiO(2) Nanoparticles To Boost the Yield of
Immobilization of an Efficient Biocatalyst
por: Pota, Giulio, et al.
Publicado: (2023) -
Bioinspired Nanoemulsions Stabilized by Phosphoethanolamine and Phosphoglycerol Lipids
por: Caianiello, Carlo, et al.
Publicado: (2020)